GUANGDONG HYBRIBIO BIOTECH

Guangdong Hybribio Biotech: Why the flat stock, weak growth, and lack of flagship products keep investors cautious.

Guangdong Hybribio Biotech (300639.SZ) trades flat at CNY 5.73, with a CNY 3.9bn cap and strong IVD portfolio spanning HPV, thalassemia and DNA diagnostics. Click to explore stable growth and global reach.

Guangdong Hybribio Biotech stays flat on Shenzhen—no growth catalyst yet, 200‑day MA above current price, 4 bn CNY cap, limited daily volume.